Baker R., Chilton S., Donaldson C., Jones-Lee M., Lancsar E., Mason H., Metcalf H., Pennington M. and Wildman J. (2011), ‘Searchers vs surveyors in estimating the monetary value of a QALY: resolving a nasty dilemma for NICE’, Health Economics, Policy and Law, 6: 435–447.
Birch S. and Donaldson C. (1987), ‘Applications of cost-benefit analysis to health care: departures from welfare economic theory’, Journal of Health Economics, 6: 211–225.
Birch S. and Gafni A. (1992), ‘Cost-effectiveness/utility analyses: do current decision rules lead us to where we want to be?’, Journal of Health Economics, 11: 279–296.
Birch S. and Gafni A. (2007), ‘Economists’ dream or nightmare? Maximising health gains from available resources using the NICE guidelines’, Health Economics, Policy and Law, 2: 193–202.
Chen M. and Bush J. (1976), ‘Maximising health system output with political and administrative constraints using mathematical programming’, Inquiry, 13: 215–227.
Cleary S., Mooney G. and McIntyre D. (2010), ‘Equity and efficiency in HIV treatment in South Africa: the contribution of mathematical programming to priority setting’, Health Economics, 19: 1166–1180.
Culyer A., McCabe C., Briggs A., Claxton K., Buxton M., Akehurst R., Sculpher M. and Brazier J. (2007), ‘Searching for a threshold, not setting one; the role of the National Institute for Health and Clinical Excellence’, Journal of Health Services Research and Policy, 12: 56–58.
Donaldson C. and Farrar S. (1993), ‘Needs assessment: developing an economic approach’, Health Policy, 25: 95–108.
Donaldson C., Bate A., Mitton C., Dionne F. and Ruta D. (2010), ‘Rational disinvestment’, Quarterly Journal of Medicine, 103: 801–807.
Drummond M. (1980), Principles of Economic Appraisal in Health Care, Oxford: Oxford University Press.
Drummond M. (2012), Twenty years of using economic evaluations for reimbursement decisions: what have we achieved? Centre for Health Economics Research Paper 75, University of York, York, UK.
Gafni A. and Birch S. (2006), ‘Incremental cost-effectiveness ratios (ICERs): the silence of the lambda’, Social Science and Medicine, 62: 2091–2100.
Gafni A., Walter S. and Birch S. (2013), ‘Uncertainty and the decision maker: assessing and managing the risk of undesirable outcomes’, Health Economics, 22: 1287–1294.
McCabe C. (2007), The Cost Effectiveness Threshold, Briefing Paper for the Methods Working Party, London: The National Institute for Health and Clinical Excellence.
Mitton C. and Donaldson C. (2004), Priority Setting Toolkit: A Guide to the Use of Economics in Health Care Decision-Making, London: BMJ Books.
Mooney G. (2003), Economics, Medicine and Health Care, 3rd edn, Harlow, UK: Pearson Education Limited.
Neumann P., Cohen J. and Weinstein M. (2014), ‘Updating cost-effectiveness analysis – the curious resilience of the $50,000 per QALY threshold’, New England Journal of Medicine, 371: 796–797.
Sendi P., Gafni A. and Birch S. (2002), ‘Opportunity costs and uncertainty in the economic evaluation of health care interventions’, Health Economics, 11: 23–31.
Tianawit S., Chongsuvivatwong V. and Birch S. (2009), ‘Optimizing the mix of basic dental services for Southern Thai school children based on resource consumption, service needs and parental preference’, Community Dentistry and Oral Epidemiology, 37: 372–380.
Torrance G., Thomas W. and Sackett D. (1972), ‘A utility maximization model for evaluation of health care programmes’, Health Services Research, 7: 118–133.
Weinstein M. (2012), ‘Decision rules for incremental cost effectiveness analysis’, in A. Jones (ed.), The Elgar Companion to Health Economics, 2nd edn, Cheltenham: Edward Elgar.